Only one paper described antiarrhythmic effect of SEA0400 [46], the other studies reported failure of NCX inhibition (SEA-0400 and KB-R7943) to reduce arrhythmia incidence in vivo. Here, TLX2 is linked to cardiac arrhythmia.